BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 26510599)

  • 1. [Production and stabilization of an integrin-binding moiety of complement component 3].
    Wu CY; Liang MX; Chen Q
    Mol Biol (Mosk); 2015; 49(5):811-6. PubMed ID: 26510599
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinct recognition of complement iC3b by integrins α
    Xu S; Wang J; Wang JH; Springer TA
    Proc Natl Acad Sci U S A; 2017 Mar; 114(13):3403-3408. PubMed ID: 28292891
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Moieties of Complement iC3b Recognized by the I-domain of Integrin αXβ2.
    Choi J; Buyannemekh D; Nham SU
    Mol Cells; 2020 Dec; 43(12):1023-1034. PubMed ID: 33372665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of CR3 (CD11b/CD18) and CR4 (CD11c/CD18) in complement-mediated phagocytosis and podosome formation by human phagocytes.
    Lukácsi S; Nagy-Baló Z; Erdei A; Sándor N; Bajtay Z
    Immunol Lett; 2017 Sep; 189():64-72. PubMed ID: 28554712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural Immunology of Complement Receptors 3 and 4.
    Vorup-Jensen T; Jensen RK
    Front Immunol; 2018; 9():2716. PubMed ID: 30534123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutagenesis of the Arg-Gly-Asp triplet in human complement component C3 does not abolish binding of iC3b to the leukocyte integrin complement receptor type III (CR3, CD11b/CD18).
    Taniguchi-Sidle A; Isenman DE
    J Biol Chem; 1992 Jan; 267(1):635-43. PubMed ID: 1730624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dysfunction of complement receptors CR3 (CD11b/18) and CR4 (CD11c/18) in pre-eclampsia: a genetic and functional study.
    Lokki AI; Teirilä L; Triebwasser M; Daly E; Bhattacharjee A; Uotila L; Llort Asens M; Kurki MI; Perola M; Auro K; Salmon JE; Daly M; Atkinson JP; Laivuori H; Fagerholm S; Meri S;
    BJOG; 2021 Jul; 128(8):1282-1291. PubMed ID: 33539617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complement Receptor 3 Forms a Compact High-Affinity Complex with iC3b.
    Jensen RK; Bajic G; Sen M; Springer TA; Vorup-Jensen T; Andersen GR
    J Immunol; 2021 Jun; 206(12):3032-3042. PubMed ID: 34117107
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular basis for complement recognition by integrin αXβ2.
    Chen X; Yu Y; Mi LZ; Walz T; Springer TA
    Proc Natl Acad Sci U S A; 2012 Mar; 109(12):4586-91. PubMed ID: 22393018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CR3 is the dominant phagocytotic complement receptor on human dendritic cells.
    Sándor N; Kristóf K; Paréj K; Pap D; Erdei A; Bajtay Z
    Immunobiology; 2013 Apr; 218(4):652-63. PubMed ID: 22906751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural insight on the recognition of surface-bound opsonins by the integrin I domain of complement receptor 3.
    Bajic G; Yatime L; Sim RB; Vorup-Jensen T; Andersen GR
    Proc Natl Acad Sci U S A; 2013 Oct; 110(41):16426-31. PubMed ID: 24065820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biologia Futura: stories about the functions of β
    Bajtay Z
    Biol Futur; 2021 Mar; 72(1):7-13. PubMed ID: 34554501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unique structure of iC3b resolved at a resolution of 24 Å by 3D-electron microscopy.
    Alcorlo M; Martínez-Barricarte R; Fernández FJ; Rodríguez-Gallego C; Round A; Vega MC; Harris CL; de Cordoba SR; Llorca O
    Proc Natl Acad Sci U S A; 2011 Aug; 108(32):13236-40. PubMed ID: 21788512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leukocyte integrins αLβ2, αMβ2 and αXβ2 as collagen receptors--receptor activation and recognition of GFOGER motif.
    Lahti M; Heino J; Käpylä J
    Int J Biochem Cell Biol; 2013 Jul; 45(7):1204-11. PubMed ID: 23542015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anchorage-dependent binding of integrin I-domain to adhesion ligands.
    Fu X; Xu Y; Wu C; Moy VT; Zhang XF
    J Mol Recognit; 2015 Jun; 28(6):385-92. PubMed ID: 25707989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beta-glucan, a "specific" biologic response modifier that uses antibodies to target tumors for cytotoxic recognition by leukocyte complement receptor type 3 (CD11b/CD18).
    Yan J; Vetvicka V; Xia Y; Coxon A; Carroll MC; Mayadas TN; Ross GD
    J Immunol; 1999 Sep; 163(6):3045-52. PubMed ID: 10477568
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancement of macrophage phagocytosis upon iC3b deposition on apoptotic cells.
    Takizawa F; Tsuji S; Nagasawa S
    FEBS Lett; 1996 Nov; 397(2-3):269-72. PubMed ID: 8955361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An interaction between CD16 and CR3 enhances iC3b binding to CR3 but is lost during differentiation of monocytes into dendritic cells.
    Preynat-Seauve O; Villiers CL; Jourdan G; Richard MJ; Plumas J; Favier A; Marche PN; Favrot MC
    Eur J Immunol; 2004 Jan; 34(1):147-55. PubMed ID: 14971040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of beta2 integrins and lipopolysaccharide-binding protein in the phagocytosis of dead Neisseria meningitidis.
    Jones HE; Strid J; Osman M; Uronen-Hansson H; Dixon G; Klein N; Wong SY; Callard RE
    Cell Microbiol; 2008 Aug; 10(8):1634-45. PubMed ID: 18397383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional studies of chronic lymphocytic leukemia B cells expressing β
    Uzonyi B; Mácsik-Valent B; Lukácsi S; Kiss R; Török K; Kremlitzka M; Bajtay Z; Demeter J; Bödör C; Erdei A
    Immunol Lett; 2017 Sep; 189():73-81. PubMed ID: 28577901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.